An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 1, 1997, Pages 81-86

  Zhang, Xichen ^a,b   Burt, Helen M ^b   Von Hoff, Daniel ^c   Dexter, Daniel ^c   Mangold, Gina ^c   Degen, Donna ^c   Oktaba, Ann Marie ^a   Hunter, William L ^a  

^a Angiogenesis Technologies Inc   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CTRC Institute for Drug Development   (United States)

Author keywords

Antitumour activity; Biodistribution; Micellar paclitaxel

Indexed keywords

COPOLYMER; CREMOPHOR; PACLITAXEL;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TISSUE LEVEL; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; LEUKEMIA P 388; LIVER; LUNG; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SPLEEN; SURVIVAL TIME; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; HUMANS; LEUKEMIA P388; MICE; MICELLES; PACLITAXEL; POLYETHYLENE GLYCOLS; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0030965632     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050630     Document Type: Article

References (24)

1. Spencer CM, Faulds D (1994) Paclitaxel: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 48:794-847
2. Onetto N, Canett R, Winograd B, Catane R, Dougan M, Grechko J, Burroughs J, Rozencwcig M (1993) Overview of paclitaxel safety. J Natl Cancer Inst Monogr 15:131-139
3. Dorr RT (1994) Pharmacology and toxicology of Cremophor EL diluent. Ann Pharmacother 28:S11 S14
4. Goldspiel BR (1994) Pharmaceutical issues: preparation, administration, stability, and compatibility with other medications. Ann Pharmacother 28:S23-S26
5. Straubinger RM (1995) Biopharmaceutics of paclitaxel (paclitaxel): formulation, activity, and pharmacokinetics. In: Suffness M (ed), Paclitaxel science and applications. CRC Press, Boca Raton, pp 237-258
6. Zhang X, Jackson JK, Burt HM (1996) Development of amphiphilic diblock copolymers as micellar carriers of paclitaxel. Int J Pharm 132:195 206
7. Scheithauer W, Clark GM, Moyer MP, Von Hoff DD (1986) New screening system for selection of anticancer drugs for treatment of human colorectal cancer. Cancer Res 46:2703-2708
8. Arteaga CL, Forseth BJ, Clark GM, Von Hoff DD (1987) A radiometric method for evaluation of chemotherapy sensitivity: results of sceening a panel of human breast cancer cell lines. Cancer Res 47:6248-6253
9. Hanauske U, Hanauske A-R, Clark GM, Tsen D, Buchok J, Von Hoff DD (1989) A new in vitro screening system for anticancer drugs for the treatment of non-small-cell lung cancer. Select Cancer Ther 5:97 111
10. Von Hoff DD, Forseth B, Warfel LE (1985) Use of a radiometric system to screen for antineoplastic agents: correlation with a tumor cloning system. Cancer Res 45:4032 4038
11. 1 mice. Cancer Chemother Pharmacol 34:465 471
12. Innocenti F, Danesi R, Paolo AD, Agen C, Nardini D, Bocci G, Tacca MD (1995) Plasma and tissue disposition of paclitaxel (paclitaxel) after intraperitoneal administration in mice. Drug Metab Dispos 23:713 717
13. Kataoka K, Kwon GS, Yokoyama M, Okano T, Sakurai Y (1993) Block copolymer micelles as vehicles for drug delivery. J Controlled Release 24: 119 132
14. Kwon GS, Kataoka K (1995) Block copolymer micelles as long-circulating drug vehicles. Adv Drug Delivery Rev 16:295-309
15. Kwon GS, Naito M, Kataoka K, Yokoyama M, Sakurai Y, Okano T (1994) Block copolymer micelles as vehicles for hydrophobic drugs. Colloids Surfaces B 2:429 434
16. Kwon G, Suwa S, Yokoyama M, Okano T, Sakurai Y, Kataoka, K (1994) Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates. J Controlled Release 29:17 23
17. Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K (1995) Physical entrapment of adriamycin in AB block copolymer micelles. Pharm Res 12:192-195
18. Yokoyama M, Okano T, Sakurai Y, Kataoka K (1994) Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin. J Controlled Release 32:269 277
19. Churchill JR, Hutchinson FG (1986) Biodegradable amphiphilic copolymers. European Patent Application No. 85304489.9
20. Piskin E, Kaitian X, Denkbas EB, Kucukyavuz Z (1995) Novel PDLLA/PEG copolymer micelles as drug carriers. J Biomater Sci Polym Ed 7:359-373
21. Hagan SA, Dunn SE, Garnett MC, Davies MC, Illum L, Davis SS (1995) PLA-PEG micelles - a novel drug delivery system. Proc 22nd Int Symp Control Rel Bioact Mater Controlled Release Society, Deerfield 22:194-195
22. Hagen SA, Davis SS, Illum L, Davies MC, Garnett MC, Taylor DC, Irving MP, Tadros ThF (1995) Estimation of the poly(ethylene glycol) chain length of L-polylactide-polyethylene glycol in aqueous dispersions using viscoelastic measurements. Langmuir 11:1482 1485
23. Kwon GS, Naito M, Yokoyama M, Okano T, Sakurai Y, Kataoka K (1993) Micelles based on AB block copolymers of poly(ethylene oxide) and poly(beta-benzyl L-aspartate). Langmuir 9:945-949
24. Evans DF, Wennerstrom H (1994) The colloidal domain, where physics, chemistry, biology, and technology meet. VCH, New York